Rubymab Ltd. - Net Worth and Insider Trading
Rubymab Ltd. Net Worth
The estimated net worth of Rubymab Ltd. is at least $1.1 Billion dollars as of 2025-01-09. Rubymab Ltd. is the 2101 Beneficial owner of Alphamab Oncology and owns about 314,000,000 shares of Alphamab Oncology (HKSE:09966) stock worth over $1.1 Billion. Details can be seen in Rubymab Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rubymab Ltd. has not made any transactions after 2023-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rubymab Ltd.
Rubymab Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rubymab Ltd. owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .
Click here to see the complete history of Rubymab Ltd.’s form 4 insider trades.
Insider Ownership Summary of Rubymab Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2023-02-09 | 2101 Beneficial owner |
Rubymab Ltd. Latest Holdings Summary
Rubymab Ltd. currently owns a total of 1 stock. Rubymab Ltd. owns 314,000,000 shares of Alphamab Oncology (HKSE:09966) as of February 9, 2023, with a value of $1.1 Billion.
Latest Holdings of Rubymab Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2023-02-09 | 314,000,000 | 3.38 | 1,061,320,000 |
Holding Weightings of Rubymab Ltd.
Rubymab Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Rubymab Ltd. has made a total of 3 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alphamab Oncology is the sale of 25,000,000 shares on February 9, 2023, which brought Rubymab Ltd. around $0.
Insider Trading History of Rubymab Ltd.
- 1
Rubymab Ltd. Trading Performance
Rubymab Ltd. Ownership Network
Rubymab Ltd. Owned Company Details
What does Alphamab Oncology do?
Who are the key executives at Alphamab Oncology?
Rubymab Ltd. is the 2101 Beneficial owner of Alphamab Oncology. Other key executives at Alphamab Oncology include 2301 Trustee South Dakota Trust Company Llc , 2305 Beneficiary of a trust Xu Ting , and 2307 Founder of a discretionary trust who can infl LIU YANG .
Alphamab Oncology (HKSE:09966) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alphamab Oncology Insider Transactions
Rubymab Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Rubymab Ltd.. Currently GuruFocus does not have mailing address information for Rubymab Ltd..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
